Kimryn Rathmell, Chief Executive Officer at Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute, shared Pelotonia’s post on LinkedIn:
“I am honored to join Pelotonia’s Board of Directors. From the moment I first learned about Pelotonia, to my first Ride Weekend, to my interactions with Pelotonia’s Board and team members, I’ve been blown away by their deep commitment and importance to our work at Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute.
Pelotonia is truly a movement that accelerates our efforts to create a cancer-free world. By building a strong connection between The James and our incredible community, Pelotonia enables us to deliver more innovative and more powerful cancer science for people facing this disease across Ohio, throughout the U.S., and beyond.
Pelotonia not only provides a substantial level of support for cutting-edge research, it specifically funds (and motivates) early-career investigators – an investment that is key to ensuring the long-term health of our field and that will pay forward to decades of advances. But most importantly, Pelotonia invigorates in us the feeling that, together, we can take on any challenge.
As a member of the Board, I am looking forward to our work together to shape Pelotonia’s future as an even stronger force against cancer, so that we reach the day when we can truly say that we have achieved a Cancer Free World.”
Quoting Pelotonia’s post:
“We’re excited to welcome Dr. Kimryn Rathmell, CEO of the Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute, to the Pelotonia Board of Directors!
A nationally recognized leader in cancer research and care and former Director of the National Cancer Institute, Dr. Rathmell brings extraordinary expertise, deep passion for community, and a strong belief in Pelotonia’s mission in her role as CEO of the OSUCCC – James.
Her added commitment through this role on the Pelotonia Board will help guide and inspire our collective efforts to further our goal of ending cancer.”
Read more insights from Kimryn Rathmell.